收藏切换
Current Status and Clinical Review Considerations of Chimeric Antigen Receptor T-cell Therapy Products Applying for Pediatric Acute Lymphoblastic Leukemia in China
收藏切换
Yunhong HUANG, Xiao LIU, Shuang LU, Chenyan GAO*
Chinese Journal of Pharmaceuticals | 2022, 53(11) : 1654 - 1658
Less
收藏切换
Chinese Journal of Pharmaceuticals | 2022, 53(11): 1654-1658
Current Status and Clinical Review Considerations of Chimeric Antigen Receptor T-cell Therapy Products Applying for Pediatric Acute Lymphoblastic Leukemia in China
Full
Yunhong HUANG, Xiao LIU, Shuang LU, Chenyan GAO*
Affiliations
  • Center for Drug Evaluation, National Medical Products Administration, Beijing 100022
Published: 2022-11-10 doi: 10.16522/j.cnki.cjph.2022.11.021
Outline
收藏切换

In recent years, with the progress of tumor immunotherapy and gene modification technology, chimeric antigen receptor T cells(CAR-T) has become a hot topic in drug research and development. CAR-T drugs targeting CD19 have significant therapeutic effects on acute lymphoblastic leukemia(ALL) in children, especially relapsed/refractory ALL with poor efficacy of conventional methods such as chemotherapy and hematopoietic stem cell transplantation. Several CAR-T products have been approved by drug regulatory administration for marketing, but no CAR-T products for children with ALL have been approved in China. This study mainly introduces the current situation of CAR-T products licensed to carry out drug clinical trials in China. Then the clinical needs and the critical elements of drug clinical research and development for acute B-cell lymphocytic leukemia in children is discussed, to provide reference for the design of registered clinical trials of similar products.

pediatric medication  /  drug evaluation  /  chimeric antigen receptor T cells  /  acute lymphoblastic leukemia  /  innovative drug
黄云虹, 刘晓, 鲁爽, 高晨燕. 我国嵌合抗原受体T细胞产品治疗儿童急性淋巴细胞白血病的申报现状和临床审评考虑. 中国医药工业杂志, 2022 , 53 (11) : 1654 -1658 . DOI: 10.16522/j.cnki.cjph.2022.11.021
Yunhong HUANG, Xiao LIU, Shuang LU, Chenyan GAO. Current Status and Clinical Review Considerations of Chimeric Antigen Receptor T-cell Therapy Products Applying for Pediatric Acute Lymphoblastic Leukemia in China[J]. Chinese Journal of Pharmaceuticals, 2022 , 53 (11) : 1654 -1658 . DOI: 10.16522/j.cnki.cjph.2022.11.021
Year 2022 volume 53 Issue 11
75
10
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2022.11.021
  • Receive Date:2022-09-10
  • Online Date:2026-11-12
  • Published:2022-11-10
Article Data
Affiliations
History
  • Received:2022-09-10
Affiliations
    Center for Drug Evaluation, National Medical Products Administration, Beijing 100022
References
Share
https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2022.11.021
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT